HRP20020426A2 - Novel thiazolidinedione derivatives as antidiabetic agents - Google Patents

Novel thiazolidinedione derivatives as antidiabetic agents Download PDF

Info

Publication number
HRP20020426A2
HRP20020426A2 HR20020426A HRP20020426A HRP20020426A2 HR P20020426 A2 HRP20020426 A2 HR P20020426A2 HR 20020426 A HR20020426 A HR 20020426A HR P20020426 A HRP20020426 A HR P20020426A HR P20020426 A2 HRP20020426 A2 HR P20020426A2
Authority
HR
Croatia
Prior art keywords
thiazolidine
dione
benzyl
ethoxy
image
Prior art date
Application number
HR20020426A
Other languages
English (en)
Croatian (hr)
Inventor
Juan Carlos Del Castillo Nieto
Marisabel Mourelle Mancini
Elisabet De Ramon Amat
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of HRP20020426A2 publication Critical patent/HRP20020426A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HR20020426A 1999-11-18 2000-11-15 Novel thiazolidinedione derivatives as antidiabetic agents HRP20020426A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (fr) 1999-11-18 2000-11-15 Nouveaux derives de thiazolidindione utilises comme agents antidiabetiques

Publications (1)

Publication Number Publication Date
HRP20020426A2 true HRP20020426A2 (en) 2004-02-29

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020426A HRP20020426A2 (en) 1999-11-18 2000-11-15 Novel thiazolidinedione derivatives as antidiabetic agents

Country Status (37)

Country Link
US (1) US7001910B1 (fr)
EP (1) EP1231211B1 (fr)
JP (1) JP2003514817A (fr)
KR (1) KR100518110B1 (fr)
CN (1) CN1159314C (fr)
AP (1) AP1330A (fr)
AR (1) AR031080A1 (fr)
AT (1) ATE241622T1 (fr)
AU (1) AU770045B2 (fr)
BG (1) BG106699A (fr)
BR (1) BR0015613A (fr)
CA (1) CA2391913A1 (fr)
CO (1) CO5261560A1 (fr)
CR (1) CR6640A (fr)
CZ (1) CZ20021654A3 (fr)
DE (1) DE60003072T2 (fr)
DK (1) DK1231211T3 (fr)
EA (1) EA004301B1 (fr)
EE (1) EE200200254A (fr)
ES (2) ES2156574B1 (fr)
GE (1) GEP20043240B (fr)
HR (1) HRP20020426A2 (fr)
HU (1) HUP0203478A2 (fr)
IL (1) IL149634A0 (fr)
IS (1) IS2014B (fr)
MA (1) MA26844A1 (fr)
MX (1) MXPA02005011A (fr)
NO (2) NO20022336L (fr)
NZ (1) NZ519264A (fr)
OA (1) OA12089A (fr)
PE (1) PE20010858A1 (fr)
PL (1) PL354877A1 (fr)
PT (1) PT1231211E (fr)
SK (1) SK6752002A3 (fr)
WO (1) WO2001036416A1 (fr)
YU (1) YU40202A (fr)
ZA (1) ZA200203906B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (fr) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Moyens pour détecter ou mesurer une activité biologique d'une toxine botulinique
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
EP1231211A1 (fr) 2002-08-14
YU40202A (sh) 2006-01-16
ES2156574A1 (es) 2001-06-16
PT1231211E (pt) 2003-09-30
SK6752002A3 (en) 2002-09-10
CN1402724A (zh) 2003-03-12
IS6386A (is) 2002-05-15
DK1231211T3 (da) 2003-10-27
IL149634A0 (en) 2002-11-10
DE60003072D1 (de) 2003-07-03
EP1231211B1 (fr) 2003-05-28
DE60003072T2 (de) 2004-04-01
GEP20043240B (en) 2004-05-25
OA12089A (en) 2006-05-04
JP2003514817A (ja) 2003-04-22
NO20022336L (no) 2002-07-09
AU1281501A (en) 2001-05-30
AP2002002512A0 (en) 2002-06-30
AR031080A1 (es) 2003-09-10
CR6640A (es) 2004-03-05
BR0015613A (pt) 2002-07-23
NZ519264A (en) 2003-10-31
MA26844A1 (fr) 2004-12-20
MXPA02005011A (es) 2003-10-14
ES2199878T3 (es) 2004-03-01
US7001910B1 (en) 2006-02-21
EA200200470A1 (ru) 2002-10-31
NO20022336D0 (no) 2002-05-15
CN1159314C (zh) 2004-07-28
EE200200254A (et) 2003-06-16
IS2014B (is) 2005-06-15
ATE241622T1 (de) 2003-06-15
CO5261560A1 (es) 2003-03-31
BG106699A (bg) 2003-02-28
PL354877A1 (en) 2004-03-08
EA004301B1 (ru) 2004-02-26
ZA200203906B (en) 2004-03-26
WO2001036416A1 (fr) 2001-05-25
CZ20021654A3 (cs) 2002-09-11
CA2391913A1 (fr) 2001-05-25
HUP0203478A2 (hu) 2003-02-28
ES2156574B1 (es) 2002-02-01
KR100518110B1 (ko) 2005-10-04
PE20010858A1 (es) 2001-08-22
NO20022379D0 (no) 2002-05-16
AU770045B2 (en) 2004-02-12
AP1330A (en) 2004-11-25
KR20020079737A (ko) 2002-10-19

Similar Documents

Publication Publication Date Title
JP4324338B2 (ja) 縮合イミダゾール化合物及び糖尿病治療薬
RU2167869C2 (ru) Соединения триазола и фармацевтическая композиция на их основе
EP0676398B1 (fr) Composés hétérocycliques ayant une activité antidiabétique, leur préparation et utilisation
US9157077B2 (en) Aminopyrimidine kinase inhibitors
EP1567112B1 (fr) THIAZOLIDIN-4-ONES POUR INHIBER LES PROTÉINES hYAK3
TW420669B (en) Pyridine type thiazolidines
KR100518110B1 (ko) 항당뇨성 제제로서의 신규한 티아졸리딘디온 유도체
DK2164843T3 (en) pyridazinone
NZ226027A (en) N-substituted amino ethoxy benzylidene-2,4-thiazolidinedione derivatives and pharmaceutical compositions
KR20040015143A (ko) 아졸릴기를 갖는 퀴놀린 유도체 및 퀴나졸린 유도체
WO2013118855A1 (fr) Noyau hétérocyclique et dérivé carbocyclique
CA2161116A1 (fr) Utilisation de thiazolidinediones pour le traitement de l'atherosclerose et des troubles lies a l'alimentation
JPH1160573A (ja) トリアジン誘導体及びテロメラーゼ阻害剤
CN101090899B (zh) 用作蛋白激酶抑制剂的2,5和2,6双取代的氮茚类似物
KR100450700B1 (ko) 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US20040023979A1 (en) Process for making substituted thiazolyl-amino pyridines
US12612396B1 (en) Modulators of beta catenin and uses thereof
US20260138977A1 (en) Modulators of beta catenin and uses thereof
JPH07330728A (ja) 複素環化合物
HK1011365B (en) Heterocyclic compounds having anti-diabetic activity, their preparation and their use

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODBC Application rejected